{
    "organizations": [],
    "uuid": "e785f0c3c58d449d6227c8e2b4c75247abb2154a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-scythian-biosciences-say-interim-q/brief-scythian-biosciences-say-interim-qtrly-loss-per-share-from-continuing-operations-0-78-idUSFWN1QH13G",
    "ord_in_thread": 0,
    "title": "BRIEF-Scythian Biosciences Say Interim Qtrly Loss Per Share From Continuing Operations $0.78",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 27, 2018 / 1:49 PM / Updated 7 minutes ago BRIEF-Scythian Biosciences Say Interim Qtrly Loss Per Share From Continuing Operations $0.78 Reuters Staff 1 Min Read Feb 27 (Reuters) - Scythian Biosciences Corp: * SCYTHIAN BIOSCIENCES CORP - INTERIM QTRLY LOSS PER SHARE FROM CONTINUING OPERATIONS $0.78 Source text: ( bit.ly/2EYwvfh ) Further company coverage:",
    "published": "2018-02-27T15:47:00.000+02:00",
    "crawled": "2018-02-27T16:08:55.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "bioscience",
        "say",
        "interim",
        "qtrly",
        "loss",
        "per",
        "share",
        "continuing",
        "operation",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "scythian",
        "bioscience",
        "corp",
        "scythian",
        "bioscience",
        "corp",
        "interim",
        "qtrly",
        "loss",
        "per",
        "share",
        "continuing",
        "operation",
        "source",
        "text",
        "company",
        "coverage"
    ]
}